Scholarlink

<p>Culturally informed care requires integrating patients’ cultural, religious, and personal values into clinical decision making. Yet many health systems lack the structural supports necessary to ensure that these values are elicited, documented, and operationalized consistently. Systemic barriers—including reliance on assumptions, insufficient documentation mechanisms, and opaque pharmaceutical labeling—undermine informed consent and trust. An ethics consultation involving the retrospective discovery of both a medication’s porcine origin and a patient’s Muslim religious identity illustrates how institutional gaps create avoidable ethical uncertainty. Because values had not been previously discussed with the patient, clinicians were unsure whether disclosure would respect autonomy or reinforce stereotypes. This case demonstrates that demographic fields alone cannot substitute for meaningful value-elicitation processes. This paper analyzes the systemic factors that impede culturally informed care and proposes structural reforms—including enhanced transparency around medication ingredients and intentional documentation practices and tools in the electronic health record (such as a Cultural and Personal Values Alert)—to support values-aligned care. These institutional changes can reduce reliance on assumptions, strengthen informed consent, and distribute ethical responsibility across clinical systems.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prescription for Change: Structural Reforms for Documenting and Operationalizing Patient Values in Clinical Care

  • 期刊论文

  • 发表日期：

    2026年4月1日

查看全文
  • Chelsey Patten,
  • Gianna Morales

摘要

Culturally informed care requires integrating patients’ cultural, religious, and personal values into clinical decision making. Yet many health systems lack the structural supports necessary to ensure that these values are elicited, documented, and operationalized consistently. Systemic barriers—including reliance on assumptions, insufficient documentation mechanisms, and opaque pharmaceutical labeling—undermine informed consent and trust. An ethics consultation involving the retrospective discovery of both a medication’s porcine origin and a patient’s Muslim religious identity illustrates how institutional gaps create avoidable ethical uncertainty. Because values had not been previously discussed with the patient, clinicians were unsure whether disclosure would respect autonomy or reinforce stereotypes. This case demonstrates that demographic fields alone cannot substitute for meaningful value-elicitation processes. This paper analyzes the systemic factors that impede culturally informed care and proposes structural reforms—including enhanced transparency around medication ingredients and intentional documentation practices and tools in the electronic health record (such as a Cultural and Personal Values Alert)—to support values-aligned care. These institutional changes can reduce reliance on assumptions, strengthen informed consent, and distribute ethical responsibility across clinical systems.